Staging and monitoring response to treatment in primary non-Hodgkin’s lymphoma of bone marrow using 18F-fluorodeoxyglucose positron emission tomography

Clinical Lymphoma

Volumn 1, Issue 4, 2001, Pages 303-306

  Matthies, Alexander ^a   Schuster, Stephen J ^a   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B cell lymphoma; Chemotherapy; FDG PET; Lymphoma staging; MRI; Treatment assessment

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; VINCRISTINE;

ABDOMEN; ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEMUR; HUMAN; LEG; LOW BACK PAIN; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PELVIS; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; THORAX;

EID: 0035058355     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2001.n.006     Document Type: Article

References (14)

1. Occurrence and prognosis of extranodal lymphomas
2. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry
3. Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia
4. Imaging of primary multifocal osseous lymphoma
5. MRI in the diagnosis of primary lymphoma of bone: Correlation with histopathology
6. MRI appearance of primary non-Hodgkin's lymphoma of bone
7. MR imaging of primary lymphoma of bone: Variability of T2-weighted signal intensity
8. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis
9. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT
10. Lymphoma: Role of wholebody 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging
11. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
12. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed imaging
13. Extranodal malignant lymphoma: Detection with FDG PET versus CT
14. Detection of lymphoma in bone marrow by whole-body positron emission tomography